Diabetes Mellitus, Type 2: all 9,590 studies
Page 27 of 96. Open to participants first (1,331), then studies with results posted, then the rest; newest registration first within each.
- A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3)CompletedNCT01126580Phase 3Results posted
- Comparison of the Blood Sugar Lowering Effect of Biphasic Insulin Aspart 30 and Insulin Glargine Both Combined With Metformin and Glimepiride in Chinese and Japanese Subjects With Type 2 Diabetes New to Insulin TreatmentCompletedNCT01123980Phase 4Results posted
- Apelin Levels and G212A Polymorphism of Apelin Receptor (APJ)CompletedNCT01121172Results posted
- A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and PharmacodynamicsCompletedNCT01119846Phase 2Results posted
- Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents FailureCompletedNCT01117350Phase 4Results posted
- Post Marketing Study in Subjects Who Have Type 2 Diabetes Using the EndoBarrier™ Gastrointestinal LinerCompletedNCT01114438Not applicableResults posted
- An Inpatient Performance Evaluation of a New Subcutaneous Glucose SensorCompletedNCT01112696Not applicableResults posted
- Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes MedicationsCompletedNCT01107886Phase 4Results posted
- The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone)CompletedNCT01106690Phase 3Results posted
- The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)CompletedNCT01106677Phase 3Results posted
- A Safety and Efficacy Study of Canagliflozin in Older Patients (55 to 80 Years of Age) With Type 2 Diabetes MellitusCompletedNCT01106651Phase 3Results posted
- The CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea)CompletedNCT01106625Phase 3Results posted
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.CompletedNCT01098539Phase 3Results posted
- Dose Ranging Study of Albiglutide in Japanese SubjectsCompletedNCT01098461Phase 2Results posted
- Integrating Depression Services Into DM ManagementCompletedNCT01098253Not applicableResults posted
- Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042)CompletedNCT01096667Phase 2Results posted
- A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin AloneCompletedNCT01095666Phase 3Results posted
- A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and ExerciseCompletedNCT01095653Phase 3Results posted
- Bioequivalence Study of Sitagliptin/Metformin Combination Tablet (MK0431A-122)CompletedNCT01093794Phase 1Results posted
- The Effects of Co-admin of Colesevelam and Sitagliptin on Glucose Metabolism in Subjects With Type 2 Diabetes MellitusCompletedNCT01092663Not applicableResults posted
- Evaluation of Omarigliptin (MK-3102) in Obese Participants and in Participants With Type 2 Diabetes (MK-3102-004)CompletedNCT01088711Phase 1Results posted
- Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal ImpairmentCompletedNCT01087502Phase 3Results posted
- Efficacy and Safety of Linagliptin in Elderly Patients With Type 2 DiabetesCompletedNCT01084005Phase 3Results posted
- The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) TrialCompletedNCT01081834Phase 3Results posted
- Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 DiabetesCompletedNCT01076647Phase 3Results posted
- Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121)CompletedNCT01076088Phase 3Results posted
- A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229)CompletedNCT01076075Phase 3Results posted
- A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)CompletedNCT01075282Phase 3Results posted
- Surgery or Lifestyle With Intensive Medical Management in the Treatment of Type 2 DiabetesCompletedNCT01073020Not applicableResults posted
- Pharmacokinetic/Pharmacodynamic Study of MP-513 With Type 2 Diabetes MellitusCompletedNCT01072331Phase 3Results posted
- To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes TherapiesCompletedNCT01068860Phase 2Results posted
- Bioequivalence Study of Fixed Dose Combination of 2.5 mg Saxagliptin/850 mg Metformin Tablet Relative to 2.5 mg Onglyza and 850 mg Glucophage Tablets Co-AdministeredCompletedNCT01068743Phase 1Results posted
- Bioequivalence Study of 500 mg and 1000 mg Glucophage (Metformin) Tablets in Healthy SubjectsCompletedNCT01068730Phase 1Results posted
- Bioequivalence Study of 2.5-mg Saxagliptin and 500-mg Glucophage in Tablets and a Fixed-dose Combination Tablet in Healthy ParticipantsCompletedNCT01068717Phase 1Results posted
- Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 DiabetesCompletedNCT01068678Phase 3Results posted
- Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 DiabetesCompletedNCT01068665Phase 3Results posted
- Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic DrugsCompletedNCT01068652Phase 4Results posted
- Phase 4 Study to Assess the Effect of Bisoprolol on Glycemic Level in Type II Diabetic Subjects With Suboptimal Blood Pressure ControlCompletedNCT01066039Phase 4Results posted
- Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182)CompletedNCT01065766Results posted
- A Study in Participants With Type 2 Diabetes MellitusCompletedNCT01064687Phase 3Results posted
- An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal ImpairmentCompletedNCT01064414Phase 3Results posted
- Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 DiabetesCompletedNCT01060059Results posted
- Study Of Safety And Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-016)CompletedNCT01059825Phase 2Results posted
- A Pan Asian Trial Comparing Efficacy and Safety of NN5401 and Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT01059812Phase 3Results posted
- Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 DiabetesCompletedNCT01059799Phase 3Results posted
- Fracture Risk With ThiazolidinedionesCompletedNCT01055223Results posted
- Effects of Once and Twice Daily Dosing Regimen of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-040)CompletedNCT01054300Phase 1Results posted
- Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With InsulinCompletedNCT01046110Phase 3Results posted
- Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 DiabetesCompletedNCT01045707Phase 3Results posted
- Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 DiabetesCompletedNCT01045447Phase 3Results posted
- A Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Doses Of PF-04937319 In Subjects With Type 2 Diabetes MellitusCompletedNCT01044537Phase 1Results posted
- Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular DiseaseCompletedNCT01042977Phase 3Results posted
- Does Pioglitazone Increase the Production of 15-EPI-Lipoxin A4?CompletedNCT01040819Phase 4Results posted
- A Local Experiential Study With Sitagliptin (an Antihyperglycemic Drug) in 30 Patients With Type 2 Diabetes Mellitus (0431-178)CompletedNCT01034111Phase 3Results posted
- Stop Emergency Room Visits for Hyperglycemia Project - District of Columbia (DC)CompletedNCT01033773Not applicableResults posted
- CANVAS - CANagliflozin cardioVascular Assessment StudyCompletedNCT01032629Phase 3Results posted
- Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and HypertensionCompletedNCT01031680Phase 3Results posted
- Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin SecretionCompletedNCT01030952Phase 4Results posted
- Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 DiabetesCompletedNCT01029886Phase 3Results posted
- A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes MellitusTerminatedNCT01029795Phase 2Results posted
- Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes MellitusCompletedNCT01029704Phase 2Results posted
- Central Mechanisms That Regulate Glucose Metabolism in HumansTerminatedNCT01028846Phase 4Results posted
- 30-Week Extension to an Initial Combination Study (24 Weeks in Duration) of Sitagliptin With Pioglitazone (0431-064)CompletedNCT01028391Phase 3Results posted
- A Study for Patients With Type 2 DiabetesCompletedNCT01027871Phase 2Results posted
- Efficacy and Safety Study of MP-513 in Combination With Thiazolidinedione in Patients With Type 2 DiabetesCompletedNCT01026194Phase 3Results posted
- A Study of LY2599506 in Patients With Type 2 DiabetesTerminatedNCT01024244Phase 2Results posted
- Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 DiabetesCompletedNCT01023581Phase 3Results posted
- Comparison of Repaglinide and Gliclazide in Chinese Subjects With Type 2 Diabetes Never Received Oral Antidiabetic Drug TreatmentCompletedNCT01022762Phase 4Results posted
- An Efficacy, Safety, and Tolerability Study for TA-7284 in Patients With Type 2 DiabetesCompletedNCT01022112Phase 2Results posted
- Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) PatientsCompletedNCT01020123Phase 2Results posted
- Linagliptin 2.5 mg Twice Daily Versus 5 mg Once Daily as add-on Therapy to Twice Daily Metformin in Type 2 DiabetesCompletedNCT01012037Phase 2Results posted
- Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 DiabetesCompletedNCT01011868Phase 2Results posted
- Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT01009580Phase 3Results posted
- Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver DiseaseCompletedNCT01006889Phase 4Results posted
- Saxagliptin Compared to Glimepiride in Elderly Type 2 Diabetes Patients, With Inadequate Glycemic Control on MetforminCompletedNCT01006603Phase 4Results posted
- Efficacy and Tolerability of Saxagliptin add-on Compared to Uptitration of Metformin in Patients With Type 2 DiabetesCompletedNCT01006590Phase 4Results posted
- Comparison of NN1250 With Insulin Glargine in Type 2 DiabetesCompletedNCT01006291Phase 3Results posted
- Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 DiabetesCompletedNCT01003184Phase 3Results posted
- Optimum Immunosuppression in Renal Transplant Recipients.New Onset Diabetes After TransplantationTerminatedNCT01002339Phase 4Results posted
- A Study of LY2189265 in Japanese Patients With Type 2 DiabetesCompletedNCT01001104Phase 2Results posted
- Monotherapy Study of MP-513 in Patients With Type 2 DiabetesCompletedNCT00998881Phase 3Results posted
- Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 DiabetesCompletedNCT00998335Phase 4Results posted
- Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With PioglitazoneCompletedNCT00996658Phase 3Results posted
- Safety & Effectiveness on Vascular Structure and Function of ACZ885 in Atherosclerosis and Either T2DM or IGT PatientsCompletedNCT00995930Phase 2Results posted
- Safety and Efficacy of Once-Daily KRP-104 in Type 2 Diabetics With Inadequate Glycemic Control on Metformin AloneCompletedNCT00995345Phase 2Results posted
- University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial)CompletedNCT00994682Phase 4Results posted
- Glycemic Effect of Colesevelam HCl (Welchol) in Patients With Type 2 DiabetesCompletedNCT00993824Phase 2/3Results posted
- Efficacy and Safety of Sitagliptin/Metformin Fixed-Dose Combination (FDC) Compared to Glimepiride in Participants With Type 2 Diabetes Mellitus (MK-0431A-202)CompletedNCT00993187Phase 4Results posted
- Study of EndoBarrier Liner for Treatment of Type 2 Diabetes StudyCompletedNCT00986349Not applicableResults posted
- Safety and Efficacy Study of EndoBarrier in Subjects With Type II Diabetes and ObesityCompletedNCT00985114Not applicableResults posted
- Dapagliflozin DPPIV Inhibitor add-on StudyCompletedNCT00984867Phase 3Results posted
- Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 DiabetesCompletedNCT00982644Phase 3Results posted
- Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)CompletedNCT00979628Phase 4Results posted
- 24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 YearsCompletedNCT00976937Phase 3Results posted
- Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 DiabetesCompletedNCT00976495Phase 2Results posted
- A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin GlargineCompletedNCT00976391Phase 3Results posted
- 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin GlargineCompletedNCT00975286Phase 3Results posted
- Efficacy and Safety Study of MP-513 in Combination With Sulfonylurea in Patients With Type 2 DiabetesCompletedNCT00974090Phase 3Results posted
- Pharmacokinetics and Pharmacodynamics of MK-8245 in Participants With Type 2 Diabetes (MK-8245-012)CompletedNCT00972322Phase 1Results posted
- Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 DiabetesCompletedNCT00972283Phase 3Results posted